Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.580
-0.010 (-0.22%)
Apr 3, 2025, 4:08 PM HKT
64.75%
Market Cap 16.43B
Revenue (ttm) 5.60B
Net Income (ttm) 688.24M
Shares Out n/a
EPS (ttm) 0.47
PE Ratio 23.87
Forward PE n/a
Dividend n/a
Ex-Dividend Date May 26, 2025
Volume 1,873,000
Average Volume 3,248,500
Open 4.540
Previous Close 4.590
Day's Range 4.520 - 4.680
52-Week Range 2.630 - 5.920
Beta 0.51
RSI 55.70
Earnings Date Mar 29, 2025

About HKG:9989

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. Its pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium A... [Read more]

Sector Healthcare
Founded 1998
Employees 2,080
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9989
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.